Campbell Alexandra, Atiya Wasef, Attia Abdallah, Ghio Michael, Nordham Kristen, Tatum Danielle, Zhang Jeanette, Harrell Kevin, Duchesne Juan, Taghavi Sharven
Tulane University School of Medicine, Department of Surgery, New Orleans, LA.
University of Pennsylvania, Department of Surgery, Philadelphia, PA.
J Am Coll Surg. 2025 May 16. doi: 10.1097/XCS.0000000000001440.
Whole blood (WB) transfusion is preferred to component therapy in hemorrhaging trauma patients. However, post-trauma complications with WB transfusion vs balanced component therapy (BCT) are not well studied. We sought to determine if WB transfusion results in decreased morbidity and mortality and hypothesized that WB transfusion would yield fewer complications.
Trauma Quality Improvement Program (TQIP) data from 2018-2021 were analyzed. Patients who received any volume of blood products within the first four hours were included. Patients <18 years old, with head or burn injuries, or missing demographic information were excluded. BCT was defined as 1:1:1 packed red blood cells:plasma:platelets, with only 1% difference between each component volume qualifying as balanced. Propensity matching was used to compare WB and BCT patients.
Before matching, there were 7,687 patients, 2,343 (30.48%) BCT and 5,344 (69.52%) WB. Post-propensity matching included 4,434 patients evenly distributed between BCT and WB groups. There were no differences in demographics between groups. The WB cohort had shorter intensive care unit (ICU) stays and significantly lower rates of acute kidney injury, acute respiratory distress syndrome, cardiac arrest, deep vein thrombosis, unplanned ICU admission, unplanned intubation, and unplanned surgery than BCT. There was no significant difference in in-hospital mortality between the two groups (p = 0.30).
WB transfusion was associated with fewer complications compared to BCT, but did not appear to be associated with improved survival. Further studies are needed to examine the mechanism driving lower incidence of complications with WB transfusion.
对于出血性创伤患者,全血(WB)输血优于成分输血治疗。然而,WB输血与平衡成分输血治疗(BCT)相比的创伤后并发症尚未得到充分研究。我们试图确定WB输血是否会降低发病率和死亡率,并假设WB输血会产生更少的并发症。
分析了2018年至2021年创伤质量改进项目(TQIP)的数据。纳入在最初四小时内接受任何血量血液制品的患者。排除年龄<18岁、有头部或烧伤损伤或缺少人口统计学信息的患者。BCT定义为红细胞悬液:血浆:血小板为1:1:1,各成分体积之间只有1%的差异被视为平衡。采用倾向匹配法比较WB组和BCT组患者。
匹配前,有7687例患者,其中2343例(30.48%)接受BCT,5344例(69.52%)接受WB输血。倾向匹配后包括4434例患者,在BCT组和WB组之间平均分配。两组之间的人口统计学特征没有差异。与BCT组相比,WB组患者的重症监护病房(ICU)住院时间更短,急性肾损伤、急性呼吸窘迫综合征、心脏骤停、深静脉血栓形成、非计划入住ICU、非计划插管和非计划手术的发生率显著更低。两组之间的住院死亡率没有显著差异(p = 0.30)。
与BCT相比,WB输血相关并发症更少,但似乎与生存率提高无关。需要进一步研究以探讨WB输血并发症发生率较低的机制。